Literature DB >> 1012334

Effects of morphine on central catecholamine turnover, blood pressure and heart rate in the rat.

C Gomes, T H Svensson, G Trolin.   

Abstract

In the unanaesthetized rat morphine caused increased dopamine (DA) turnover, unchanged or possibly increased central noradrenaline (NA) turnover (utilization), hypertension and tachycardia. In the anaesthetized rat, brain DA turnover was not affected, whereas the NA-turnover was decelerated, particularly in some brain regions, e.g. cerebral cortex and medulla oblongata, and hypotension and bradycardia was obtained. Both biochemical and cardiovascular effects of morphine were antagonized by naloxone. A very small dose of morphine (1 mg/kg) caused tachycardia also in the anaesthetized rat. Decerebration just inferior to the inferior colliculus abolished the conscious rat, but left the circulatory, depressant actions of the drug unchanged. The morphine-induced cardiovascular effects, particularly the hypotension and bradycardia in the anaesthetized animal, are suggested to be related to, or mediated by, the effects of the drug on brain NA-mechanisms, especially in view of several similarities between morphine and the antihypertensive alpha-adrenergic agonist clonidine. Whereas higher brain structures appear important in the excitatory, circulatory effects of morphine, structures below the decerebration level, e.g. medulla oblongata, appear primarily involved in the hypotension and bradycardia obtained in the anaesthetized animal. Possibly, morphine has a diphasic dose-response curve with respect to cardiovascular function and, by inference, on brain noradrenergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1012334     DOI: 10.1007/bf00507846

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  A pharmacokinetic approach to morphine analgesia and its relation to regional turnover of rat brain catecholamines.

Authors:  B Dahlström; G Paalzow; L Paalzow
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

2.  Tonic and reflex functions of medullary sympathetic cardiovascular centers.

Authors:  R S ALEXANDER
Journal:  J Neurophysiol       Date:  1946-05       Impact factor: 2.714

3.  Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

Authors:  K Starke; H Montel
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

4.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Cardiovascular effects of morphine, pethidine, diamorphine and nalorphine on the cat and rabbit.

Authors:  H F Grundy
Journal:  Br J Pharmacol       Date:  1971-06       Impact factor: 8.739

6.  Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

Authors:  N E Andén; T Magnusson; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

Review 8.  Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines.

Authors:  J Axelrod
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

Review 9.  Central sympathetic transmitters and hypertension.

Authors:  M Henning
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06

10.  Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl.

Authors:  M Laubie; H Schmitt; J Canellas; J Roquebert; P Demichel
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

View more
  7 in total

1.  Presynaptic receptor systems on the noradrenergic neurones of rat brain.

Authors:  H D Taube; K Starke; E Borowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

2.  Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

3.  Evidence for involvement of central noradrenergic neurons in the cardiovascular depression induced by morphine in the rat.

Authors:  C Gomes; T H Svensson; G Trolin
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

4.  Antagonism of morphine-induced central stimulation in mice by small doses of catecholamine-receptor agonists.

Authors:  U Strömbom; T H Svensson
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

5.  Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

6.  The effects of acute and chronic administration of morphine on the turnover of brain and adrenal catecholamines in rats.

Authors:  C Guaza; A Torrellas; S Borrell; J Borrell
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.

Authors:  D L Walker; T McGlynn; C Grey; M Ragozzino; P E Gold
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.